Gates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement Post author:GHIAA Admin Post published:April 25, 2022 Post category: Continue ReadingGates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement
Cellscript – BioNTech mRNA Technology Patent Sublicense Post author:GHIAA Admin Post published:March 17, 2022 Post category: Continue ReadingCellscript – BioNTech mRNA Technology Patent Sublicense
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 21, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 19, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
CEPI CfP3i Template Funding Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingCEPI CfP3i Template Funding Agreement
IMI 1 Model Grant Agreement Post author:GHIAA Editor Post published:May 21, 2020 Post category: Continue ReadingIMI 1 Model Grant Agreement
MPP – ViiV, Dolutegravir License Agreement Post author:GHIAA Editor Post published:May 21, 2020 Post category: Continue ReadingMPP – ViiV, Dolutegravir License Agreement
AbbVie – MPP, HIV Antiretroviral License Agreement Post author:GHIAA Editor Post published:May 21, 2020 Post category: Continue ReadingAbbVie – MPP, HIV Antiretroviral License Agreement